Register entry
- Registered sites
- 0
- Active NDC listings
- 16
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1616 active NDC listings: 16 human prescription drug. By marketing category: ANDA 16.
| Dosage form | NDCs |
|---|---|
| injection, powder, lyophilized, for solution | 3 |
| injection, solution | 3 |
| tablet, film coated | 3 |
| tablet, film coated, extended release | 3 |
| tablet | 2 |
| tablet, delayed release | 2 |
| Route | NDCs |
|---|---|
| oral | 10 |
| intravenous | 6 |
| Labeller name on the listing | NDCs |
|---|---|
| archis pharma llc | 16 |
Catalogue
Marketed products
16| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CHROMIC CHLORIDE | CHROMIC CHLORIDE | injection, solution, intravenous | 72819-235ANDA |
| CUPRIC CHLORIDE | CUPRIC CHLORIDE | injection, solution, intravenous | 72819-234ANDA |
| Diclofenac Potassium | diclofenac potassium | tablet, film coated, oral | 72819-151ANDA |
| Doxepin | Doxepin | tablet, film coated, oral | 72819-161ANDA |
| Doxepin | Doxepin | tablet, film coated, oral | 72819-162ANDA |
| Mitomycin | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 72819-152ANDA |
| Mitomycin | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 72819-153ANDA |
| Mitomycin | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 72819-154ANDA |
| Mycophenolic Acid | mycophenilic acid | tablet, delayed release, oral | 72819-155ANDA |
| Mycophenolic Acid | mycophenilic acid | tablet, delayed release, oral | 72819-156ANDA |
| Nicardipine Hydrochloride | nicardipine hydrochloride | injection, solution, intravenous | 72819-149ANDA |
| Paliperidone | paliperidone | tablet, film coated, extended release, oral | 72819-158ANDA |
| Paliperidone | paliperidone | tablet, film coated, extended release, oral | 72819-159ANDA |
| Paliperidone | paliperidone | tablet, film coated, extended release, oral | 72819-160ANDA |
| imatinib mesylate | imatinib mesylate | tablet, oral | 72819-185ANDA |
| imatinib mesylate | imatinib mesylate | tablet, oral | 72819-186ANDA |
Compare
Other companies listing mitomycin
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- Concord Biotech Limited3 sites · 42 NDC
- Zhejiang Hisun Pharmaceutical Co., Ltd.3 sites · 27 NDC
- MEDISCA Inc.2 sites · 305 NDC
- ACCORD HEALTHCARE LIMITED2 sites · 242 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Darmerica, LLC1 site · 212 NDC
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Wuxi Fortune Pharmaceutical Co., Ltd.1 site · 5 NDC
- BluePoint Laboratories Inc.0 sites · 352 NDC
Enquiry
Common questions
- Is Archis Pharma LLC FDA approved?
- Archis Pharma LLC holds no registered establishment of its own; 16 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Archis Pharma LLC make?
- 16 products are listed under Archis Pharma LLC in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; injection, solution; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.